Updated call text found here (link).
In their quest to find new and better methods to make cancer cells more susceptible to treatment, Karin Lindkvist and her research group at Lund University in Sweden are looking into the world of molecules, using the X-rays at the MAX IV laboratory. The researchers believe that limiting the cells’ access to sugar will make
While studying a class of copper-containing enzymes, a team of researchers discovered and characterised a new family of fungal proteins. Their study has now been published on Nature Chemical Biology, including analysis performed at BioMAX. The article is published together with a parallel study that sheds light on one of the potential biological roles of
Image: participants at the MAX IV User Meeting gathered for the opening plenary session at the Scandic Star hotel in Lund. LUND—MAX IV hosted the 31st User Meeting at the Scandic Star hotel from 23-25 September. The theme this year was Developing MAX IV: with the users, for the users. Over 300 scientists, researchers,
At October 31, 2019, the BioMAX team performed together with AstraZeneca the first 8-hour remote operation experiment. The researchers from AstraZeneca in Mölndal connected successfully to the BioMAX beamline remotely (left picture) and collected data from many samples during their 8-hour beamtime. Ana Gonzalez from the BioMAX team observed together with Helena Käck from AstraZeneca
For the first time, researchers at the University of Copenhagen have mapped how bacterial cells trigger their defence against outside attacks. This could affect how diseases are fought in the future. With the aid of highly advanced microscopes and synchrotron sources, researchers from the University of Copenhagen have gained critical insight into how bacteria function
Controlling the rate of processes of electronically excited states of organic molecules is key to obtain efficient and stable organic-electronic devices. The insights gained from the last century of research within the fields of energy and electron transfer has been conveyed into organic electronic devices recently. However, a key parameter which still not completely resolved in
MAX IV pairs up with Sprint Bioscience, a listed drug development company, in a new project to improve how companies can benefit from new, faster X-ray fragment screening experiments, while still protecting their valuable information during analysis at FragMAX. Recently, the project was granted with 500 000 SEK from Sweden’s innovation agency Vinnova. More or
The spring call for proposals for eight beamlines at MAX IV closed 19 March with a total of 228 proposals from 28 countries. The number of applications is on par with proposals received when the former MAX-lab peaked, which shows that the demand from users is high as well as is their confidence in getting excellent tools
The samples at BioMAX beamline are very sensitive biomolecule crystals. It could, for example, be one of the many proteins you have in your body. They only last for a short time in the intense X-ray light before being damaged and needs to be placed exactly right before the researchers switch on the beam.